This is an automatically translated article.
Currently on the market there are many articles around the Rexulti drug line, but it is still not detailed. The following article would like to provide readers with all the information about the uses, usage and notes when using Rexulti to treat diseases.
1. What is Rexulti?
Rexulti drug belongs to the psychotropic group with the content of Brexpiprazol 3mg. Rexulti is used to treat psychosis.
Rexulti is prepared in the form of film-coated tablets, packed in a box of 1 bottle x 30 tablets, researched and manufactured at Otsuka Pharmaceutical Co., Ltd. Tokushima Factory - JAPAN.
2. What does Rexulti do?
Rexulti is an antipsychotic drug that works by altering the action of chemicals in the brain.Rexulti is used to treat the symptoms of schizophrenia .
Rexulti is also used with other medicines to treat major depressive disorder in adults.
3. Contraindications to using Rexulti
Rexulti should not be used in the following cases:
Elderly people with mental disorders related to dementia; Persons under 18 years old; People with hypersensitivity or allergy to Brexpiprazole or any of the excipients in the drug; The patient had reactions involving facial swelling, urticaria, rash and anaphylaxis.
4. Dosage and usage of Rexulti
How to use:
Rexulti can be taken with or without food. Take with plenty of water, especially in hot weather and when exercising, because it is possible to become dehydrated easily while taking Rexulti. Dosage for schizophrenia:
Initial dose: 1 mg orally once daily on days 1 to 4. Based on individual clinical response and tolerability, schedule titration to 2 mg once a day on day 5 to day 7, then to 4mg once a day on day 8; Maintenance dose: 2 to 4mg orally once a day; Maximum dose: 4 mg/day; Recommended Adult Dose for Depression:
Initial dose: 0.5mg to 1mg orally once a day; Titration regimen: Based on clinical response and tolerability, dose increments should be made at weekly intervals. Titrate to 1mg once daily, then increase to 2mg once daily; Maintenance dose: 2mg orally once a day; Maximum dose: 3mg/day. The above dosage is for reference only, the specific dose will be determined by the doctor/pharmacist based on age and disease progression.
5. Notes before taking Rexulti
Here are some precautions when using Rexulti:
Rexulti may increase the risk of death in older adults with dementia-related psychosis, so its use is not recommended; You should not use Rexulti if you are allergic to Brexpiprazole; Tell your doctor if you have ever had diabetes or high blood sugar, liver and kidney disease, high cholesterol or triglycerides (a type of fat in the blood), heart problems, high blood pressure or low blood pressure, heart attack, stroke, a seizure, low white blood cell count (WBC); Young people taking medication should have regular check-ups and visits by their doctor to avoid thoughts of suicide; Taking Rexulti during the last 3 months of pregnancy can cause problems with feeding, breathing, and withdrawal symptoms in the newborn. If you are pregnant, tell your doctor right away. Do not stop taking Rexulti without the advice of your doctor or pharmacist; There have been no reports on the safety of Rexulti in nursing women. Therefore, it is necessary to use caution while breastfeeding, consult your doctor before deciding to use; Rexulti is not authorized for use by persons under the age of 18; Avoid driving or operating machinery while taking Rexulti; During the use of Rexulti, the patient should not stop taking the drug suddenly because it can make the condition worse; Rexulti may cause high blood sugar (hyperglycemia). If you have diabetes, check your blood sugar often while you are taking this medicine; Store Rexulti at room temperature, away from moisture and heat.
6. What are the side effects of Rexulti?
During the use of Rexulti, patients may experience some unwanted side effects such as:
Allergic reactions: Difficulty breathing, hives, swelling of the face, lips, tongue or throat; Changes in mood or behavior, panic attacks, anxiety, irritability, trouble sleeping, impulsivity, agitation, hostility, irritability, aggression, restlessness, hyperactivity, depression or thoughts about commit suicide, hurt yourself,...; Severe, irreversible movement disorders; Uncontrollable facial muscle movements (chewing, smirking, frowning, tongue movements, blinking or eye movements); Difficulty swallowing ; Feeling hot, poor heat resistance; A seizure (convulsions); Possible fainting; high blood sugar - increased thirst, dry mouth, increased urination, fruity breath; low white blood cell count--fever, skin sores, mouth sores, sore throat, cough, trouble breathing; severe nervous system reaction--very stiff (rigid) muscles, confusion, high fever, sweating, fast or irregular heartbeat, tremors; signs of a blood clot--sudden numbness or weakness, problems with vision or speech, swelling or redness in an arm/leg; Increased sex drive, unusual gambling or any other desire; Gaining weight, feeling restless or unable to sit still. The above is not a complete list of all the side effects that patients may experience when using Rexulti. Call the medical center or go to the nearest medical facility if unusual symptoms persist for appropriate treatment.
7. Rexulti . drug interactions
Rexulti in combination with certain drugs is sometimes unsafe and interactions can occur. Other drugs that may interact with Rexulti include prescription and over-the-counter drugs, vitamins, and herbal products.
Also, consider taking the drug with alcohol, tobacco, alcoholic beverages or fermentation, because the agents in these foods can change the composition of the medicine.
Inform the doctor about all medicines that the patient is taking or has stopped taking.
The article has provided information about the uses, dosage and precautions when using Rexulti. Always strictly follow the dosage and instructions of your doctor/pharmacist while taking Rexulti.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
